Referral and adjuvant treatment patterns after nephrectomy in high‐risk locoregional renal cell carcinoma

BACKGROUND: It is unclear whether patients with renal cell carcinoma (RCC) are routinely assessed for recurrence risk post‐nephrectomy and whether patients at high recurrence risk are seen by providers who can evaluate candidacy for adjuvant systemic therapy (AST) and clinical trials. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzimitrowicz, Hannah, Esterberg, Elizabeth, Miles, LaStella, Zanotti, Giovanni, Borham, Azah, Harrison, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683553/
https://www.ncbi.nlm.nih.gov/pubmed/34751002
http://dx.doi.org/10.1002/cam4.4407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683553/
https://www.ncbi.nlm.nih.gov/pubmed/34751002
http://dx.doi.org/10.1002/cam4.4407

Ejemplares similares